Jennings GS - Search Results

1

In vivo formation of aflatoxin B1-DNA adducts in parenchymal and non-parenchymal cells of rat liver.

Jennings GS, Oesch F, Steinberg P. Jennings GS, et al. Carcinogenesis. 1992 May;13(5):831-5. doi: 10.1093/carcin/13.5.831. Carcinogenesis. 1992. PMID: 1586995

2

Metabolism and cytotoxicity of aflatoxin B1 in cultured rat hepatocytes and nonparenchymal cells: implications for tumorigenesis.

Jennings GS, Heck R, Oesch F, Steinberg P. Jennings GS, et al. Toxicol Appl Pharmacol. 1994 Nov;129(1):86-94. doi: 10.1006/taap.1994.1231. Toxicol Appl Pharmacol. 1994. PMID: 7974499

3

The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models.

Bäumer W, Wlaź P, Jennings G, Rundfeldt C. Bäumer W, et al. Eur J Pharmacol. 2010 Feb 25;628(1-3):226-32. doi: 10.1016/j.ejphar.2009.11.018. Epub 2009 Nov 14. Eur J Pharmacol. 2010. PMID: 19917276

4

Gene transfer into hepatocytes and human liver tissue by baculovirus vectors.

Sandig V, Hofmann C, Steinert S, Jennings G, Schlag P, Strauss M. Sandig V, et al. Hum Gene Ther. 1996 Oct 20;7(16):1937-45. doi: 10.1089/hum.1996.7.16-1937. Hum Gene Ther. 1996. PMID: 8930653

5

Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c-myc in the liver.

Klocke R, Bartels T, Jennings G, Brand K, Halter R, Strauss M, Paul D. Klocke R, et al. FASEB J. 2001 Jun;15(8):1404-6. doi: 10.1096/fj.00-0487fje. FASEB J. 2001. PMID: 11387238 No abstract available.

6

Hepatocyte-specific binding of L/S-HBV particles expressed in insect cells.

Hofmann C, Sandig V, Kirillova I, Jennings G, Rudolph M, Schlag P, Strauss M. Hofmann C, et al. Biol Chem Hoppe Seyler. 1995 Mar;376(3):173-8. doi: 10.1515/bchm3.1995.376.3.173. Biol Chem Hoppe Seyler. 1995. PMID: 7612194

7

Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.

Löser P, Jennings GS, Strauss M, Sandig V. Löser P, et al. Among authors: jennings gs. J Virol. 1998 Jan;72(1):180-90. doi: 10.1128/JVI.72.1.180-190.1998. J Virol. 1998. PMID: 9420214 Free PMC article.

8

Gene therapy: prospects for treatment of liver disease.

Sandig V, Hofmann C, Löser P, Jennings G, Strauss M. Sandig V, et al. Z Gastroenterol. 1996 Jun;34 Suppl 3:25-6. Z Gastroenterol. 1996. PMID: 8767451 Review.

9

Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.

Botschuijver S, van Diest SA, van Thiel IAM, Saia RS, Strik AS, Yu Z, Maria-Ferreira D, Welting O, Keszthelyi D, Jennings G, Heinsbroek SEM, Elferink RPO, Schuren FHJ, de Jonge WJ, van den Wijngaard RM. Botschuijver S, et al. Sci Rep. 2019 Aug 29;9(1):12530. doi: 10.1038/s41598-019-49096-y. Sci Rep. 2019. PMID: 31467355 Free PMC article.

10

Computational screening for membrane-directed inhibitors of mast cell activation.

Batista J, Friedrichson T, Schlechtingen G, Braxmeier T, Jennings G, Bajorath J. Batista J, et al. Eur J Med Chem. 2010 Jun;45(6):2700-4. doi: 10.1016/j.ejmech.2010.01.061. Epub 2010 Feb 1. Eur J Med Chem. 2010. PMID: 20153565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters